{
    "code": 0,
    "data": [
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93b3e0a9-36af-41f2-be6a-ad0fbd3b1ea1.pdf",
            "news_date": "2026-02-11 16:21:28"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b383cd8a-56af-4e7e-b5bb-52d8646cfe47.pdf",
            "news_date": "2026-02-10 11:30:06"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As attached",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d63dbc5f-582e-4c69-a3e0-3d30342c2adc.pdf",
            "news_date": "2026-02-09 19:24:44"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc215724-313f-4123-9a0e-1583944b869b.pdf",
            "news_date": "2026-02-09 15:45:58"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ef65ae5-6fa2-40c7-a965-87aedc2c33bb.pdf",
            "news_date": "2026-02-09 15:43:20"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter & Nine Months December 2025",
            "news_body": "Outcome of Meeting",
            "news_id": "fb51628f-81b9-4fcf-84dd-d3a3158c9144",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80302ab0-7804-492b-ae4c-f7cddcc92967.pdf",
            "news_date": "2026-02-09 15:31:01",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter & Nine Months December 2025",
            "news_body": "Outcome of Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80302ab0-7804-492b-ae4c-f7cddcc92967.pdf",
            "news_date": "2026-02-09 15:31:01"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Meeting",
            "news_body": "Outcome of Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=439dab08-f7fc-4ea0-b55b-6eafeba80897.pdf",
            "news_date": "2026-02-09 15:24:45"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1ba5f25-8074-41f3-b30a-ebb63a17da8c.pdf",
            "news_date": "2026-02-03 10:20:23"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "As per Attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d72487b-e434-476c-9a8b-47f271981fa7.pdf",
            "news_date": "2026-01-08 10:47:04"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Un-Audited Financial Results For The Third Quarter & Nine Months Ended 31St December 2025.",
            "news_body": "Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve  take on record the Un-audited financial results for the third quarter & nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b126e999-3ddc-441e-9aac-88ebc9106e83.pdf",
            "news_date": "2026-01-06 15:54:08"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7786a1b-4971-4176-9542-2e8708664258.pdf",
            "news_date": "2026-01-01 14:28:52"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=053a783f-586e-4af7-ba3c-a65ddc17912e.pdf",
            "news_date": "2025-12-31 19:38:11"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Volume Movement Letter",
            "news_body": "Volume Movement Letter",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3de4c29b-a5c6-4e85-92e2-4952bab5484a.pdf",
            "news_date": "2025-12-31 19:36:28"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on December 31 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-12-31 13:21:57"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49b31534-3225-45be-b649-b96fd6e6cfd9.pdf",
            "news_date": "2025-12-23 15:45:02"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "Disclosure under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa2b580e-f335-415d-8a6b-bb2d98144fe1.pdf",
            "news_date": "2025-12-22 12:34:37"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d59105c8-9fed-4a9a-b10c-76eb3f9b1d84.pdf",
            "news_date": "2025-12-18 16:13:11"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cc0fe05-7d2a-4d41-9c63-0c7b119ed755.pdf",
            "news_date": "2025-12-12 20:33:36"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74518c69-f1f7-433e-a118-fe85c7559025.pdf",
            "news_date": "2025-11-19 20:18:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0a1097e-b549-41db-a93f-2824802d1354.pdf",
            "news_date": "2025-11-10 13:05:11"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bcf0758-9202-4ba8-bf89-c74e476d0468.pdf",
            "news_date": "2025-11-10 13:00:38"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=690440fc-6362-4dc0-aab4-977dd294ed50.pdf",
            "news_date": "2025-11-06 21:37:48"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c53f12e4-1b62-4433-8bd7-e315ec21a65b.pdf",
            "news_date": "2025-11-06 16:49:14"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Outcome of meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcb8219b-c887-46b5-8abe-1dfd55f0b0d1.pdf",
            "news_date": "2025-11-06 16:37:18"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results Ended Quater September 2025",
            "news_body": "As per attachment",
            "news_id": "e9781c1c-7225-4309-aec3-92f71036c154",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265993f-3554-4004-9d0a-2861effa6779.pdf",
            "news_date": "2025-11-06 16:29:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results Ended Quater September 2025",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265993f-3554-4004-9d0a-2861effa6779.pdf",
            "news_date": "2025-11-06 16:29:36"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "news_id": "58ff2e76-1e05-4edc-8b9f-5cde4f0042c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf",
            "news_date": "2025-11-06 16:25:32",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59ebf753-033f-40f4-ac54-fa8b6e063f12.pdf",
            "news_date": "2025-11-06 16:25:32"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome",
            "news_body": "Outcome of meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=354f69a8-1088-4c00-b535-70dab226c56a.pdf",
            "news_date": "2025-11-06 16:19:53"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b66ef6c-b2ae-48a9-b239-c144e4040589.pdf",
            "news_date": "2025-10-30 16:44:53"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddf56b8d-567d-482d-9bcf-6d767c561529.pdf",
            "news_date": "2025-10-29 12:46:55"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter & Half Year Ended 30Th September 2025.",
            "news_body": "Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve Approval of Un-audited financial results for the quarter & half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a43edd8-bd56-449d-93cd-8fb14d42eecf.pdf",
            "news_date": "2025-10-27 14:26:08"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df64adda-59ab-4a69-b4cf-e36805c39846.pdf",
            "news_date": "2025-10-08 12:26:37"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b413ed5-7f4f-49c4-b4ba-1cbcc058a86e.pdf",
            "news_date": "2025-09-29 17:12:19"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation regarding 100 days campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2837dde3-a67b-42df-873e-af893e39fc25.pdf",
            "news_date": "2025-09-25 17:05:34"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "Disclosure under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=884717d0-cffa-4e40-8370-05df06e84aad.pdf",
            "news_date": "2025-09-08 17:31:58"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Company forays into Oncology with Jemperli & Zejula  bringing  precisions therapies for Gynaecological Cancers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46944d82-d32f-4451-8131-079b599b809e.pdf",
            "news_date": "2025-08-25 11:03:22"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "Company forays into oncology with jemperli & Zejula bringing precision therapies for Gynaecological cancers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c2277f7-e465-4d8b-a651-4ee4f526df5f.pdf",
            "news_date": "2025-08-25 11:00:36"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=999563ee-42d0-4112-8aac-5afd95a14161.pdf",
            "news_date": "2025-08-08 10:31:15"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45e96924-23b4-48af-9cbf-e9c891d682bd.pdf",
            "news_date": "2025-08-05 13:16:13"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5c7214a-dd5e-4fac-b0a3-3f42e86ce839.pdf",
            "news_date": "2025-08-04 11:44:45"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Rumour verification - Regulation 30(11)",
            "news_body": "Clarification on news item appearing in Moneycontrol.com",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90c29a20-efa2-4201-b13a-da8406c80233.pdf",
            "news_date": "2025-08-04 11:27:28"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d73a4b51-33a0-4763-8ae0-861c669a5ab1.pdf",
            "news_date": "2025-08-02 12:31:10"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 1 2025 with reference to news appeared in https://www.moneycontrol.com dated August 1 2025 quoting \"Trump Tariff News Live: GSK and AstraZeneca among top companies told to cut US prices or else\".<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-08-01 16:48:34"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "news_id": "0a71de07-5e9e-42ca-bde8-058110ef9201",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11959022-3697-4e9d-9517-932286dd43f6.pdf",
            "news_date": "2025-08-01 15:22:49",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11959022-3697-4e9d-9517-932286dd43f6.pdf",
            "news_date": "2025-08-01 15:22:49"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=104dc7d0-ab70-49a6-a553-8a291438cf9e.pdf",
            "news_date": "2025-08-01 13:33:16"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Meeting",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98976d10-d6de-4133-99a9-92d4e5a618d1.pdf",
            "news_date": "2025-08-01 12:37:29"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Quarter Ended 30Th June 2025",
            "news_body": "As per attachment",
            "news_id": "c9e806bd-03e2-482d-b8ae-d4a7ccc6b618",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1382030-78c7-4eef-a7c3-867ae9fd65b6.pdf",
            "news_date": "2025-08-01 12:35:32",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Quarter Ended 30Th June 2025",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1382030-78c7-4eef-a7c3-867ae9fd65b6.pdf",
            "news_date": "2025-08-01 12:35:32"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fd6b900-0ef7-46a2-ba47-deaf5f7f2a0e.pdf",
            "news_date": "2025-07-28 11:48:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=162ca074-3095-4ef7-b57c-03b37ee99e7e.pdf",
            "news_date": "2025-07-23 15:58:34"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7a4a8f-d6d3-4bc3-b347-e9eed1b09de5.pdf",
            "news_date": "2025-07-11 12:43:04"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83e159fa-0cc9-46e8-9a77-c1e1bec2be62.pdf",
            "news_date": "2025-07-09 16:23:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation\r\n",
            "news_body": "Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Board Meeting Intimation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9b08ac5-c6dd-40a3-a370-98622c8fc908.pdf",
            "news_date": "2025-07-04 15:22:46"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Outcome Of AGM",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2504ee5-d3a4-4b08-a359-fccd592c51a8.pdf",
            "news_date": "2025-06-27 16:10:56"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5227d682-09ae-4bd3-ab0f-1b5fe61d41cd.pdf",
            "news_date": "2025-06-27 16:08:22"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Outcome of AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9202a3d-819d-4688-af59-7631da9ab5e6.pdf",
            "news_date": "2025-06-27 16:06:52"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42d7e11e-9e82-4c36-a250-cc8b043a1433.pdf",
            "news_date": "2025-06-27 14:05:20"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23b82839-ae40-41d7-b73f-8a415248c891.pdf",
            "news_date": "2025-06-26 11:37:48"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Analyst Meet",
            "news_body": "Please refer attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4be39923-116d-4627-9276-7cd1dd8ca290.pdf",
            "news_date": "2025-06-20 16:02:06"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ff02aac-4379-4903-8475-d7ed7c50ba7b.pdf",
            "news_date": "2025-06-19 16:00:56"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=583339d4-2389-4c01-8679-6aa0e0490c66.pdf",
            "news_date": "2025-06-05 12:39:30"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Letter To Shareholders For Annual Report Link",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61889553-a8fc-4534-9bc1-e1872e521524.pdf",
            "news_date": "2025-06-05 12:03:22"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c20d520e-e92a-4b73-8757-d62b2674cd43.pdf",
            "news_date": "2025-06-05 11:47:54"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "100Th Annual General Meeting On 27Th June 2025",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23ceb09b-6c97-45f7-a4c4-e107dcfd8140.pdf",
            "news_date": "2025-06-03 14:55:57"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "BRSR Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d29441a-0012-4587-aa4a-943f598d252d.pdf",
            "news_date": "2025-06-03 14:54:02"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72fcf18f-8def-4198-9977-dfc64762d12c.pdf",
            "news_date": "2025-06-03 14:51:31"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be68c8ae-f67e-43c5-82a4-901d7ece203b.pdf",
            "news_date": "2025-06-02 19:10:18"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "Disclosure under Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=242bca0f-0070-4bfe-84f3-c84d32d58f89.pdf",
            "news_date": "2025-05-16 16:18:29"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9d508e3-b106-46f2-a54a-834f1116b8d9.pdf",
            "news_date": "2025-05-15 16:16:32"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63316060-e7fc-4a3a-9f3d-783c010c03bf.pdf",
            "news_date": "2025-05-15 16:15:07"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ad14593-1179-49a4-820c-f5a9a3321097.pdf",
            "news_date": "2025-05-15 16:13:07"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97134894-27d4-4fc8-8324-de1201cb2131.pdf",
            "news_date": "2025-05-14 17:00:12"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5337b0d4-804c-4b04-90ec-35f3aa196d76.pdf",
            "news_date": "2025-05-13 19:11:18"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Parikh & Associates As Secretarial Auditor Of The Company \r\n",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31761809-d76e-4f97-bd5a-96443c1478e0.pdf",
            "news_date": "2025-05-13 17:12:36"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "100Th Annual General Meeting On 27Th June 2025",
            "news_body": "100Th Annual General Meeting  on 27th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=910a70e4-7382-4f36-8462-bc8a3ad7002f.pdf",
            "news_date": "2025-05-13 16:44:04"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a5759a5-7dc4-401b-bc9c-fa922cabfa0c.pdf",
            "news_date": "2025-05-13 16:35:31"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c12822fc-67df-482f-88a0-3af3608a62f8.pdf",
            "news_date": "2025-05-13 16:34:22"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Dividend Updates",
            "caption": "Announcement under Regulation 30 (LODR)-Dividend Updates",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e26c920f-1b2e-4a1d-88e3-767e4a167c8e.pdf",
            "news_date": "2025-05-13 16:31:21"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "news_id": "e075d53c-2e2c-47f8-9924-74d976f374fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c5b8816-0d2a-4289-9c0d-588f9f46e3fa.pdf",
            "news_date": "2025-05-13 16:29:41",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c5b8816-0d2a-4289-9c0d-588f9f46e3fa.pdf",
            "news_date": "2025-05-13 16:29:41"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Final Dividend 30Th May 2025",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83fbe94e-c993-4334-8ee6-bf842be3cbcd.pdf",
            "news_date": "2025-05-13 16:27:35"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6483fa89-8101-49bc-8aab-520f950927bd.pdf",
            "news_date": "2025-05-13 16:25:36"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7216f28-bb06-4b04-ba29-e12e921b6bd1.pdf",
            "news_date": "2025-05-13 16:13:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Dividend/AGM",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=172314ec-0edd-4e54-b11a-75f1a429cb69.pdf",
            "news_date": "2025-05-13 16:12:02"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5100e2c6-6403-42f0-9a36-3733c85a2d13.pdf",
            "news_date": "2025-05-13 16:09:46"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Meeting",
            "news_body": "outcome of meeting",
            "news_id": "ef598a9d-a7cf-45da-bb9b-fe66764f6479",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4590c00b-921d-4566-aed5-22db996e0397.pdf",
            "news_date": "2025-05-13 16:04:00",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Meeting",
            "news_body": "outcome of meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4590c00b-921d-4566-aed5-22db996e0397.pdf",
            "news_date": "2025-05-13 16:04:00"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Meeting",
            "news_body": "Outcome of Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76b524f1-db3f-40a8-9ddb-74d585c8e30b.pdf",
            "news_date": "2025-05-13 15:57:53"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba3d96fd-8855-42ab-8b22-a15c6fb374f6.pdf",
            "news_date": "2025-05-08 17:55:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e640e79-3300-442d-94ff-16781bbf859e.pdf",
            "news_date": "2025-05-02 21:33:10"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d89ca75-8708-4a2e-a2ea-2387b66884e9.pdf",
            "news_date": "2025-04-29 21:29:30"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a803043a-3865-4d68-a6a8-01c796269daa.pdf",
            "news_date": "2025-04-29 20:10:08"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45a93c0a-8b1d-4629-bb90-b46b426b0cf7.pdf",
            "news_date": "2025-04-29 20:09:07"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Increase In Volumes",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=344702d6-c348-4ee8-ab3e-93cc005b5abd.pdf",
            "news_date": "2025-04-25 12:00:20"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Increase In Volumes",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=688131e4-9e91-4a7c-9d60-9d031a9b4135.pdf",
            "news_date": "2025-04-25 11:29:10"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) For The Quarter / Year Ended 31St March 2025",
            "news_body": "Glaxosmithkline Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5fd8452-4628-4a23-9214-4419a124862c.pdf",
            "news_date": "2025-04-17 16:52:21"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10efa691-5017-43c0-9433-78ac547d96a6.pdf",
            "news_date": "2025-04-11 20:35:18"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ed112b7-c56e-42a4-a766-aa7180657d54.pdf",
            "news_date": "2025-04-09 11:38:02"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07926775-8559-430f-882b-f341d9fc8f31.pdf",
            "news_date": "2025-04-04 15:27:51"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0619cc9a-8834-47e6-8b9f-d15772de3e23.pdf",
            "news_date": "2025-04-04 15:26:24"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "As per attachment",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e9bea3d-9ebe-4bd0-9d99-72df4bde4240.pdf",
            "news_date": "2025-03-31 12:47:40"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Postal Ballot",
            "caption": "Postal Ballot Notice",
            "news_body": "Postal Ballot Notice",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e920872-dcc3-4727-ad0e-d24d6ef9aff1.pdf",
            "news_date": "2025-03-28 14:27:25"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Directorate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=260f8bd5-7eae-425b-bbac-e539ffbaa0a9.pdf",
            "news_date": "2025-03-26 19:46:40"
        },
        {
            "co_code": 195,
            "bse_code": 500660,
            "isin": "INE159A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Change In Directorate",
            "news_body": "outcome of Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6af4de4-b601-4be0-8f5d-f56bad964d13.pdf",
            "news_date": "2025-03-26 19:45:13"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Ouctome",
            "news_body": "outcome",
            "news_id": "d4d7d452-0267-4694-97a6-2c115783cd9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c890f688-407a-4563-be7f-47717ba8ddd0.pdf",
            "news_date": "2025-02-14 15:27:26",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financials Results For Quarter & Half Year Ended 30Th September 2024",
            "news_body": "outcome of meeting",
            "news_id": "63cf203c-b29b-4e5e-a04b-11301a855efc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d91ea356-37e8-40ac-b25f-2ecf13939fb2.pdf",
            "news_date": "2024-10-29 15:44:28",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For June 2024",
            "news_body": "Outcome of Meeting",
            "news_id": "23476937-1df0-4f50-acb9-04ba26664ffc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f41ff-ff4e-4ea2-a3ca-421fb7cd0ff4.pdf",
            "news_date": "2024-08-02 15:35:00",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "e82192cf-005d-4993-aac4-4e763c14b2e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe7defcb-06e2-4078-94ea-6d00b87116e8.pdf",
            "news_date": "2024-05-17 13:58:57",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months Ended 31 St December 2023",
            "news_body": "Unaudited Financial Results for third quarter and nine months ended 31st December 2023",
            "news_id": "3c31797b-709e-4fba-9fda-eb9673dd488a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9583a0a-dce2-46ff-b201-4663b167c6a5.pdf",
            "news_date": "2024-02-12 16:55:43",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Second Quarter & Half Year Ended 30Th September 2023",
            "news_body": "Unaudited financials Results for second quarter & half year ended 30th September 2023",
            "news_id": "0a1d6517-bc7d-4535-ab55-97037e959a72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b74c9dfc-3eae-448e-aec8-27a24d500426.pdf",
            "news_date": "2023-11-09 16:35:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2023",
            "news_body": "Unaudited Results for quarter ended 30th June 2023",
            "news_id": "c05268d3-07f6-4e3b-adb7-632067f1dc64",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaa49b3b-043d-4c26-8691-1b40b06210e3.pdf",
            "news_date": "2023-07-26 13:45:52",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2023<BR> <BR>",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2023<BR>  <BR>",
            "news_id": "ec9c01b5-e9a9-430b-8b72-e7f8d7d7d231",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be947997-bbb9-493b-ba8d-6834bdf09ba9.pdf",
            "news_date": "2023-07-26 13:43:34",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For Year Ended March 2023",
            "news_body": "Audited Results for year ended March 2023",
            "news_id": "f645da61-434d-4f1c-8638-f4404c4d3ca8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efc3fe99-e328-4251-8fe1-690601f597ca.pdf",
            "news_date": "2023-05-17 16:53:29",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board MEeting",
            "news_id": "3c9e3471-82ce-4238-b907-7429838ce206",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea99123-0315-4323-9ae3-e75593dc75cf.pdf",
            "news_date": "2023-05-17 16:51:57",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months 31St December 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter & nine months 31st December 2022",
            "news_id": "63429401-4ec4-483b-902b-5a5437c0b85d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e77c2646-e68f-453f-8f4c-ccae7e0236e6.pdf",
            "news_date": "2023-02-07 16:11:40",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter & Nine Months 31St December 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter & nine months 31st December 2022",
            "news_id": "289ad67d-407f-45c9-8a8c-42af2601c439",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73a06a68-28ef-4d7c-a142-8f77ec66f70d.pdf",
            "news_date": "2023-02-07 16:10:21",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose disclosure of Related Party Transactions for the half year endedSeptember 30, 2022.",
            "news_id": "1df3f809-3d92-4747-99fb-90b8ae05af32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52e06b90-1236-48ad-8c39-d3110b1ec95b.pdf",
            "news_date": "2022-11-22 11:49:21",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Second Quarter & Half Year Ended 30Th September 2022",
            "news_body": "Outcome of Board Meeting",
            "news_id": "dc68fff4-5303-4cc5-a5d3-28bebbb03a13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9567279f-83e2-4dab-a586-9f2b0cb45348.pdf",
            "news_date": "2022-11-11 16:08:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022",
            "news_id": "76f371d9-faa0-4acd-bc3a-2b3cabce18c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02f92110-ebd1-4865-b5bb-fb1db5d352d8.pdf",
            "news_date": "2022-07-25 17:41:35",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The First Quarter Ended 30Th June 2022",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the first quarter ended 30th June 2022",
            "news_id": "0b21d0fc-41d7-4d25-8753-feb42e20a637",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7b53f19-a935-471e-a704-1568d7ff49da.pdf",
            "news_date": "2022-07-25 17:40:06",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions",
            "news_body": "Submission of Disclosure on Related Party Transactions",
            "news_id": "632da926-6e42-4f1c-a04b-a3d320c68d4f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a86eb839-e253-4483-81f0-73f513bd23ae.pdf",
            "news_date": "2022-05-30 22:10:42",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Meeting",
            "news_body": "outcome of meeting",
            "news_id": "4f87a4f4-d72f-481d-ae1a-cbf5812bea22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a07fb38-a2f4-45a7-a385-57bd6f66c5e6.pdf",
            "news_date": "2022-05-16 16:37:02",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Year Ended 31St March 2022",
            "news_body": "outcome of meeting",
            "news_id": "83927c4d-ac78-4533-9395-f26983f199b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c2d17ae-d8e3-47b2-9298-4b6155466df9.pdf",
            "news_date": "2022-05-16 16:35:36",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ended 31St December 2021",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021",
            "news_id": "e9d7f1a5-f8c0-40a7-b225-b863b1e9a676",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcc3b893-44e0-42c5-b9ff-104195c5c2f2.pdf",
            "news_date": "2022-02-07 16:14:38",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited (Standalone And Consolidated) Financial Results For The Third Quarter And Nine Months Ended 31St December 2021",
            "news_body": "Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2021",
            "news_id": "95f0ac7f-31ac-49d4-bc60-d17e8464d996",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3aa101e6-71e4-4b2c-94a2-b8f11f2e2f95.pdf",
            "news_date": "2022-02-07 16:12:49",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Un-Audited Standalone and Consolidated Financial Results and Limited Review Report<BR> for the quarter & half year ended 30th September 2021.",
            "news_id": "eec606b0-2514-4b00-8269-730872bbe0ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92b68e14-501c-43e3-a3d5-e3c8a0532d18.pdf",
            "news_date": "2021-10-29 16:42:38",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results And Limited Review Report For The Quarter & Half Year Ended 30Th September 2021",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "ae660426-49ae-4424-8fb2-852cc3d5d606",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d6722dd-f22c-4099-aef8-7ebc95ecdc6d.pdf",
            "news_date": "2021-10-29 16:41:02",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results And Limited Review Report For The Quarter Ended 30Th June 2021.<BR>",
            "news_body": "<BR> Pursuant to Clause 33 read with Clause 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, please find enclosed herewith the Un-Audited Standalone and Consolidated Financial Results and Limited Review Report for the quarter ended 30th June 2021.<BR>",
            "news_id": "8e8462c3-450f-451a-aa74-eceda4f28526",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b8b8ba5-4c7a-41cd-8bd6-323f8b7e2e10.pdf",
            "news_date": "2021-07-26 20:33:50",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions For 31St March 2021",
            "news_body": "In Compliance with Regulation 23(9) of SEBI (listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, we hereby submit the attached Related<BR> Party Transactions, on consolidated basis, drawn in accordance with applicable accounting standards for period ended 31st  March 2021",
            "news_id": "2e852b30-6cd7-473e-813d-f6ea7957c0cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c3750cd-a89f-4afa-a7fe-3701c013e0db.pdf",
            "news_date": "2021-06-15 16:10:30",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "965b3d02-1de5-4423-95ed-fd41b38fb07e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ddb78c9-0877-4767-9867-bb846a2e3ff6.pdf",
            "news_date": "2021-05-18 19:18:28",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GLAXO",
            "disp": "GlaxoSmithKline Pharmaceuticals",
            "bse_code": 500660,
            "isin": "INE159A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter & Year Ended 31St March  2021.",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "bd5e5e24-58ce-437e-9d2f-3f65ab532ba0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8a0bdb5-e494-422c-9344-ad2a5b10162f.pdf",
            "news_date": "2021-05-18 19:16:50",
            "seo": "glaxosmithkline-pharmaceuticals-ltd",
            "ltp": 2699.3,
            "ch": 76.40000000000009,
            "pch": 2.912806435624694,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 1153,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}